Key facts
| Price (PPV) | 218 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | irbésartan |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09CA04 |
| Manufacturer | SANOFI AVENTIS MAROC |
| Presentation | Boîte de 28 |
| Nature | Médicament |
| Hospital price | 136.30 MAD |
| Data collected on | 9/8/2026 |
Indications
APROVEL® est indiqué chez l’adulte dans le traitement de l’hypertension artérielle essentielle. Il est également indiqué dans le traitement de l’atteinte rénale chez les patients adultes hypertendus diabétiques de type 2, dans le cadre de la prise en charge par un médicament antihypertenseur.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 5 other products contain the same active substance as Aprovel 300 mg (Irbésartan), at the same strength and in the same dosage form. For the same pack size (Boîte de 28), the cheapest is Avepro 300 mg (SOTHEMA) at 150 MAD, i.e. 31 % less than Aprovel 300 mg (218 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Avepro 300 mg | SOTHEMA | Boite de 28 | 150 MAD | 5.36 / unit | −31 % |
| Irbesar Sun 300 mg | SUN PHARMACEUTICALS NORTH AFRICA S.A | Boite de 28 | 150 MAD | 5.36 / unit | −31 % |
| Vepran 300 mg | SOTHEMA | Boite de 28 | 150 MAD | 5.36 / unit | −31 % |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Avepro 300 mg | SOTHEMA | Boite de 14 | 84 MAD | 6 / unit |
| Vezar 300 mg | SYNTHEMEDIC | Boite de 30 | 150.20 MAD | 5.01 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Aprovel 300 mg
Aprovel 300 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by SANOFI AVENTIS MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Aprovel 300 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Aprovel 300 mg
Answers to common questions from Moroccan patients about this drug.